October 15, 2020 -- Sestina Bio, a new company developing an automated synthetic biology platform, has been launched with seed funding. Sestina also is the first company to be launched from the Foresite Labs incubator.
Funding was provided by Foresite Capital, General Inception, and OMX Ventures and will be used to develop digital cellular engineering and phenotyping platforms and support initial product development.
The platforms will include instruments for single-cell genome editing, tools for single-cell phenotyping, and closed-loop machine learning-driven design and control of experiments, which cumulatively will form the next generation of automated synthetic biology toolkits.
Copyright © 2020 scienceboard.net